RARLITEE Trademark

Trademark Overview


On Wednesday, October 28, 2020, a trademark application was filed for RARLITEE with the United States Patent and Trademark Office. The USPTO has given the RARLITEE trademark a serial number of 90285038. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 13, 2024. This trademark is owned by Gilead Sciences Ireland UC. The RARLITEE trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
rarlitee

General Information


Serial Number90285038
Word MarkRARLITEE
Filing DateWednesday, October 28, 2020
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2024

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, December 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events


Event DateEvent Description
Monday, March 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, November 1, 2020NEW APPLICATION ENTERED
Sunday, December 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 29, 2021ASSIGNED TO EXAMINER
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 25, 2021SOU TEAS EXTENSION RECEIVED
Monday, October 25, 2021SOU EXTENSION 1 FILED
Monday, October 25, 2021SOU EXTENSION 1 GRANTED
Wednesday, October 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 5, 2022SOU TEAS EXTENSION RECEIVED
Thursday, May 5, 2022SOU EXTENSION 2 FILED
Thursday, May 5, 2022SOU EXTENSION 2 GRANTED
Saturday, May 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 14, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 14, 2022SOU EXTENSION 3 FILED
Monday, November 14, 2022SOU EXTENSION 3 GRANTED
Wednesday, November 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 4, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 4, 2023SOU EXTENSION 4 FILED
Thursday, May 4, 2023SOU EXTENSION 4 GRANTED
Saturday, May 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU EXTENSION 5 FILED
Thursday, November 30, 2023SOU EXTENSION 5 GRANTED
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, June 6, 2024ASSIGNED TO PETITION STAFF
Tuesday, June 11, 2024PETITION INQUIRY LETTER ISSUED
Friday, June 28, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, June 28, 2024NOTICE OF ALLOWANCE CANCELLED
Friday, June 28, 2024CASE RETURNED TO EXAMINATION
Wednesday, July 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 26, 2024TEAS RESPONSE TO PETITION INQUIRY LETTER